Unknown

Dataset Information

0

PHLPP2 suppresses the NF-?B pathway by inactivating IKK? kinase.

ABSTRACT: The NF-?B growth pathway is constitutively activated in many cancers but its activation mechanism is unclear in most cases. We show that PHLPP2 interacts with IKK? kinase, decreases its phosphorylation and the subsequent NF-?B activation in cancer cells. PHLPP2 is progressively lost in glioma and colorectal cancer and acts as a bona fide tumor suppressor, depending on IKK? expression in cells. Physiologically, IKK? activation by growth factors requires the formation of the Bcl10-MALT1 ubiquitin-ligase complex leading to NEMO/IKK? non-degradative ubiquitination and IKK? phosphorylation. PHLPP2 opposes the formation of this complex through interaction with Bcl10 and competitive displacement of MALT1 from Bcl10. Conversely, PHLPP2 loss enhances Bcl10-MALT1 complex formation, NEMO ubiquitination and subsequent IKK? phosphorylation, resulting in increased NF-?B-dependent transcription of multiple target genes. Our results reveal PHLPP2 as a new biomarker of cancer progression, and implicate it as major negative regulator of NF-?B signaling.

SUBMITTER: Agarwal NK 

PROVIDER: S-EPMC3996652 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase.

Agarwal Nitin Kumar NK   Zhu Xiaoping X   Gagea Mihai M   White Charles L CL   Cote Gilbert G   Georgescu Maria-Magdalena MM  

Oncotarget 20140201 3

The NF-κB growth pathway is constitutively activated in many cancers but its activation mechanism is unclear in most cases. We show that PHLPP2 interacts with IKKβ kinase, decreases its phosphorylation and the subsequent NF-κB activation in cancer cells. PHLPP2 is progressively lost in glioma and colorectal cancer and acts as a bona fide tumor suppressor, depending on IKKβ expression in cells. Physiologically, IKKβ activation by growth factors requires the formation of the Bcl10-MALT1 ubiquitin-  ...[more]

Similar Datasets

Unknown POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway.
| S-EPMC5636987 | biostudies-literature
Unknown PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signaling.
| S-EPMC7645261 | biostudies-literature
Unknown Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK?/NF-?B signaling pathway in lung cancer cells.
| S-EPMC4161895 | biostudies-literature
Unknown ASFV pD345L protein negatively regulates NF-κB signalling by inhibiting IKK kinase activity.
| S-EPMC9034082 | biostudies-literature
Unknown Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation.
| S-EPMC6470148 | biostudies-literature
Unknown PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-?B signaling
| S-SCDT-EMBOR-2019-49305V1 | biostudies-other
Unknown The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis.
| S-EPMC5696377 | biostudies-literature
Unknown Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
| S-EPMC2265190 | biostudies-other
Unknown AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 Macrophages.
| S-EPMC4723067 | biostudies-literature
Unknown Inhibitory-?B Kinase (IKK) ? and Nuclear Factor-?B (NF?B)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets.
| S-EPMC6210445 | biostudies-literature